comparemela.com

Latest Breaking News On - Nxera pharma - Page 1 : comparemela.com

Nxera Pharma (OTCMKTS:SOLTF) Share Price Crosses Below 200-Day Moving Average of $9.89

Shares of Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $9.89 and traded as low as $8.85. Nxera Pharma shares last traded at $8.85, with a volume of 1,000 shares trading […]

Japan
Bermuda
United-kingdom
Switzerland
United-states
Ultibro-breezhaler
Seebri-breezhaler
Nxera-pharma
Nxera-pharma-co-ltd
Nxera-pharma-company-profile
Get-free-report
Nxera-pharma-daily

Nxera Pharma to Receive $4.6 Million in Milestone Payments

Nxera Pharma to Receive $4.6 Million in Milestone Payments
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Seoul
Soult-ukpyolsi
South-korea
Japan
United-kingdom
Cambridge
Cambridgeshire
London
City-of
Tokyo
Maya-bennison
Nxerapharma-youtube

Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals

Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Cambridge
Cambridgeshire
Japan
Seoul
Soult-ukpyolsi
South-korea
London
City-of
Tokyo
Erica-hollingsworth
Shinichiro-nishishita

Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area

Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug .

London
City-of
United-kingdom
Japan
Tokyo
Seoul
Soult-ukpyolsi
South-korea
Cambridge
Cambridgeshire
Shinichiro-nishishita
Kentaro-tahara

Neurocrine, a regular name on Wall Street's M&A lists, elevates BD chief to succeed founder and CEO

Neurocrine, a regular name on Wall Street's M&A lists, elevates BD chief to succeed founder and CEO
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Japan
California
United-states
Portugal
Portuguese
American
Michel-vounatsos
Sosei-heptares
Neurocrine-biosciences
Kyle-gano
Chris-viehbacher
Nxera-pharma

vimarsana © 2020. All Rights Reserved.